












Abstract: This paper explores existing and 
emerging drug problems and responses in the 
city environment. It addresses four areas: urban 
spaces and drug use, businesses and recreational 
drug use, city-level drugs policies and the 
coordination and funding of city-level policies. The 
paper is based on three data sources: a review of 
scientific literature, grey literature, and national 
reports from the Reitox network of the European 
Monitoring Centre for Drugs and Drug Addiction. 
Two main categories of city-level problems related 
to drug use are identified: one centres on 
problematic forms of drug use such as use of 
opioids and injection, the other on recreational 
use of licit and illicit substances. So-called open 
drug scenes, where drug users congregate and 
high-risk drug use takes place in public spaces, 
were found in several cities. The open drug 
scenes vary by visibility, size and the type of 
location in which they occur. Cities differ in the 
level of access they provide for problem drug 
users to opioid substitution treatment, needle and 
syringe exchange programmes and low-threshold 
services, and in the geographical coverage of 
such interventions. In cities, extensive nightlife 
zones can be found. Concentrations of bars and 
clubs, and in some cases cannabis coffee shops 
and head shops, provide a focus for recreational 
drug use. Different measures have been 
implemented in nightlife settings to respond to 
drug use, including drug prevention interventions 
and ‘pill testing’ services. This study identified 10 
capital cities with an active drugs strategy 
document. Generally, city authorities are formally 
responsible for the coordination of drugs policy in 
the municipality. A number of Europe’s capital 
cities allocate a dedicated budget to the 
implementation of their drugs strategies.
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I Summary
The European Union (EU) is one of the most urbanised areas 
in the world, with more than two-thirds of its population living 
in cities. Some of the most concentrated levels of drug use 
and the most problematic consumption practices can be 
found in cities. Modern cities play host to a diverse set of drug-
using communities, from the recreational to the problematic, 
and a range of related health, social and security problems. 
The unique infrastructure of a city makes it an environment 
where drug problems are likely to be experienced. For 
example, cities may contain air, sea, road and rail transport 
hubs, large nightlife areas, disadvantaged areas, locations for 
sex work, different types of drug markets and clusters of drug 
treatment services. Despite this, city-level drug policies have 
been overshadowed by events at national and international 
levels in much of the analysis and debate surrounding drug 
policies. This creates a situation where the origins of new 
problems and responses to them may be obscured by a policy 
debate focused at a higher level.
This paper explores existing and emerging illicit drug problems 
and responses and the different forms they can take in the city 
environment. It addresses four areas: urban spaces and drug 
use, businesses and recreational drug use, city-level drugs 
policies, and the coordination and funding of city-level 
policies. The paper is based on three data sources: a review of 
scientific literature, grey literature, and national reports from 
the Reitox network of the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA). Qualitative data from 
the three sources were analysed and a documentary account 
of the key issues was generated, forming the basis of 
this paper.
Over time, the challenges linked to drug problems have led to 
the development of a range of responses, often in cities where 
problems were acute. For example, low-threshold harm 
reduction services, needle and syringe exchange programmes 
and drug consumption facilities all arose out of initiatives at 
city level in response to injecting drug use. More recently, 
innovative new laws and the strategic application of existing 
laws have been used to remove new psychoactive substances 
from the shelves of head shops.
Open drug scenes, which vary in visibility, size and the sites in 
which they occur, were identified in eight cities (Berlin, 
Brussels, Bucharest, Copenhagen, Dublin, Oslo, Paris and 
Prague). Most of the scenes active in the cities discussed here 
can be categorised as either ‘concentrated’ or ‘dispersed’ 
open scenes. In practice, many cities’ open drug scenes move 
back and forth between both of these types and defy neat 
categorisation. These open drug scenes revolve around 
complex patterns of drug use involving multiple substances. 
While most such scenes are primarily opioid-based, polydrug 
use involving multiple licit and illicit substances is the norm.
At city level, provision of key support to problem and 
marginalised drug users often takes place in low-threshold 
settings. Typically, the services offered involve the provision of 
emergency shelter, clothing and food, alongside interventions 
including counselling, psychosocial support and harm 
reduction advice. Access to needle and syringe exchange 
programmes and opioid substitution treatment (methadone, 
buprenorphine) are core interventions targeting injectors and 
opioid users in urban settings. To a limited extent, drug 
consumption facilities have been developed in certain cities, 
aiming to reach marginalised users, engage them with support 
services and prevent overdoses and the transmission of 
blood-borne viruses (HIV, hepatitis B and C viruses).
Most cities have extensive nightlife zones where recreational 
drug use takes place. These areas have a large number of 
retail outlets for the sale of alcohol (bars, off-licences), 
nightclubs and various venues where music-related events 
take place. This creates a situation where parts of the city 
experience a significant increase in the number of people 
using drugs in the evenings and at weekends. A wide range of 
substances are used in these settings, including alcohol, 
prescription medicines, cannabis, new psychoactive 
substances, ecstasy, cocaine and amphetamines.
Cities are also a hub for interventions and services aimed at 
preventing, treating and reducing the harms related to 
recreational drug use. Various measures have been developed 
to respond to licit and illicit drug use in nightlife settings. 
Selected prevention strategies are used to target the club-
going population in some cities. ‘Pill testing’ services allow 
users to obtain a chemical analysis of tablets or powders that 
they have. This service has been present in several cities at 
various times, including Amsterdam, Berlin, Paris, Vienna and 
Zurich. Similar services are also available in Madrid and other 
Spanish cities.
A range of businesses in cities serve differing drug 
consumption practices. Nine cities (Amsterdam, Berlin, 
Bratislava, Bucharest, Dublin, Lisbon, Madrid, Riga and 
Warsaw) reported that street-based shops that had been 
selling new psychoactive substances in the past either had 
been closed or no longer stocked new psychoactive 
substances. In all cases, the closure of the shops or removal of 
the products was driven by legislative measures. The 
Netherlands differs from other EU Member States in its policy 
of tolerance towards retail stores for the sale of cannabis, 
known locally as ‘coffee shops’. In December 2011, there were 
651 coffee shops in the Netherlands. Just under half of the 
shops are based in the large cities of Amsterdam, Rotterdam 
and The Hague.
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are also marked by high levels of unemployment and social 
disadvantage (European Commission, 2011).
It is generally in the city that social problems have evolved and 
where new forms of inequality and healthcare challenges are 
identified. The effects of social changes, including the 
challenges arising from globalisation, migration, shifting 
demographics, urban renewal and changing employment 
opportunities, have an acute impact on cities. In this context, 
drug problems and responses to them are an important factor 
in the mix of elements that shape the fabric of a city. The 
European Commission has noted that ‘cities are places where 
both problems emerge and solutions are found’ (European 
Commission, 2011, p. iii). This paper takes a look at some of 
the city-level drugs policy issues in Europe. It explores existing 
and emerging illicit drug problems and responses and the 
different forms they take in the city environment.
The unique infrastructure of a city has an impact on the nature 
of the drug problems that occur there. It is around cities that 
the major seaports, airports and road and rail gateways are 
centred. The presence of transport hubs poses a challenge for 
customs and law enforcement authorities, which must 
address illicit drugs moving across borders and within 
countries.
Modern cities play host to a diverse set of drug-using 
populations. Cities frequently contain areas marked by urban 
deprivation and restricted social mobility. Changes from, for 
example, industrial to knowledge-based economies can leave 
many unemployed and subject to socioeconomic 
disadvantage (Punch, 2005). While problem drug use, such as 
injecting heroin or other opioids, can be found in all 
communities, it has typically been concentrated in 
disadvantaged communities in cities. The presence of large 
numbers of injecting drug users within a city can create its 
own problems, such as increasing the likelihood of open drug 
scenes. This experience has been documented in several 
European cities, such as Amsterdam, Frankfurt, Merseyside 
and Zurich (Stadt Frankfurt am Main, 1991). A concentration 
of social and drug treatment services can be found in most 
cities, in response to the presence of marginalised drug users 
living in and commuting to these areas. Similarly, drug users 
involved in prostitution are often based in cities, as this is 
where red-light districts and other locations for sex work 
are found.
In addition, entertainment and nightlife districts are a common 
feature of cities, and the high concentration of nightlife and 
music venues serves to attract party-goers, including 
recreational drug users. Cities that are known for their nightlife 
or more liberal policies towards drug use often experience 
drug tourism; examples include Amsterdam and Prague, as 
well as other ‘party cities’ with established scenes, such as 
Berlin and Ibiza town (EMCDDA, 2012).
While the adoption of drugs strategies at national level has 
become a standard feature of the public administrative 
response to drug problems in Europe, a more unclear and 
complex situation exists at city level. A city-level policy can be 
defined as the measures taken by local policy actors to 
address all or some aspects of drug problems in a specific 
urban location. This study identified ten capital cities (Berlin, 
Bucharest, Copenhagen, Helsinki, Lisbon, Prague, Madrid, 
Stockholm, Vienna and Warsaw) with a strategy document 
that could be considered currently active. This was the most 
common approach to expressing city-level drugs policy.
Generally, formal responsibility for the coordination of drugs 
policy lies with the city authorities. In some cases, this 
designated responsibility is established in law. Cities may 
differ in how the drugs strategy is managed, with some using a 
dedicated drugs policy unit and others a generic policy unit 
with a range of other responsibilities. In cities where no formal 
coordination structures exist at city level, other national, 
regional or local structures are ultimately responsible for 
implementing drugs strategies. Nevertheless, in all cases, city 
authorities are involved in multiple direct and indirect ways. 
Local- and city-level drug monitoring systems are operational 
in some cities and are used to inform policy and response 
planning. These include Antenna in Amsterdam, the Føre Var 
system in Bergen, MoySD in Frankfurt and the Trend system in 
seven French cities. In Poland, the National Bureau for Drug 
Prevention coordinates a network of local drug monitors at 
commune level.
A number of Europe’s capital cities have a dedicated budget 
attached to their drugs strategies. The available expenditure 
figures range from EUR 6.5 million in Berlin to EUR 29.4 million 
in Madrid. Clearly, the amounts spent vary widely; however, 
this can be explained by the fact that, for example, some cities 
fund specific measures by existing agencies, whereas others 
fund entire agencies that play a key role in the city’s overall 
response to drug issues.
I  Drug problems at city level: an introduction
The European Union (EU) is one of the most urbanised areas 
in the world, with more than two-thirds of its population living 
in cities (European Commission, 2011). Globally, the trend 
towards increased urbanisation is predicted to result in 70 % 
of people residing in cities by 2050 (World Health 
Organization, 2010). This unprecedented shift in the location 
and density of the population presents policymakers with 
challenges and opportunities. Modern cities are centres for 
economic activity and growth, often driving national 
economies. Yet cities are characterised by paradoxes: while 
they present new employment and social opportunities, they 
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I Urban spaces and drug use
Drug problems frequently emerge within urban environments 
before spreading to other areas. Consequently, cities may 
offer an observation window on certain new drug trends and 
developments at an early stage. Like any other behaviour, drug 
use does not take place in a social vacuum. The interrelation 
between the drugs being consumed, the psychological state 
of the user and the environment in which the use happens is 
important (Zinberg, 1984). However, the role of the social and 
built environment has been under-reported in drugs policy 
analysis. Modern cities contain multiple risk environments 
where various types of drug use, from the problematic to the 
recreational, take place (Rhodes, 2002). Research involving 
the geocoding of overdose locations has underlined the role of 
certain urban environments, as has other work on the impact 
of place on treatment outcomes for methadone clients 
(Klimas et al., 2014; Murphy and Comiskey, 2014). This section 
of the paper considers drug use in public spaces and the open 
drug scenes that are not uncommon in urban environments 
and which may be facilitated by the structural features 
commonly found in modern cities.
Over time, the challenges linked to drug problems have led to 
the development of a range of responses, often in cities where 
problems were acute. For example, low-threshold harm 
reduction services, needle and syringe exchange programmes 
and drug consumption facilities all arose out of initiatives at 
city level in response to injecting drug use. In recent years, 
innovative new laws and the strategic application of existing 
laws have been used to remove new psychoactive substances 
from the shelves of head shops. Cities have historically been 
at the forefront of developing new solutions to drug problems 
because, as Room (2006, p. 136) puts it, ‘the city is the level 
of government which has the immediate responsibility to deal 
with many of the problems from psychoactive substance use 
and intoxication.’ Many initiatives are first developed or piloted 
by service providers in the voluntary and community sectors, 
before being adopted by the authorities and rolled out as 
established and sanctioned interventions. Thus, it is at city 
level that the movement of harm reduction interventions, for 
example, from the margins to the mainstream of national 
drugs policies started to take place (Hedrich et al., 2008).
In recent years, city-level drugs policies have been 
overshadowed by events at national and international levels in 
much of the analysis and debate surrounding drugs policies. 
This creates a situation where the origins of new problems and 
responses to them are obscured by a policy debate focused at 
a higher level.
The second conference of the organisation European Cities on 
Drug Policy, held in 1991, created the impetus for a review of 
city drugs policies that presented policymakers with 
information that complemented and went beyond 
epidemiological data (Bless et al., 1993). Subsequently, drug 
problems, the occurrence of public nuisance and the 
experience of the general public, for example, have all been 
the subject of various reports at city level (Bless et al., 1993; 
Korf et al., 1998; Renn and Lange, 1996). This paper revisits 
the city as an important unit for drugs policy analysis. It 
provides a means for policymakers and professionals in the 
drugs field to take stock of what is currently happening in 
some of Europe’s main cities. The paper seeks to provide an 
orientation point for researchers embarking on comparative 
analysis at city level. In doing this, the present paper aims to 
contribute to a revitalisation of interest in cities as being at the 
core of drugs policy.
The paper presents information on drugs policies in a number 
of European cities (see box ‘Data sources’), aiming to provide 
readers with an accessible and up-to-date overview of the 
area. It begins with a look at key areas closely associated with 
city-level drug problems and the local responses that have 
been put in place to tackle them. The paper concludes with a 
review of some of the ways in which city-level policies have 
been constructed and drug problems have been monitored.
This paper is based on three data sources: a review of 
scientific literature, grey literature and national reports 
from the Reitox network of the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) (1). A 
systematic review of peer-reviewed scientific journals 
was conducted to explore and build a picture of city-
level drugs policy issues. At the same time, a systematic 
Internet search for grey literature, such as conference 
reports and city-level policy documents, was 
undertaken. Reports on city-level drugs policies from 
the national focal points of 18 European countries were 
analysed. These countries provided information about 
their capital cities, while some also gave details about 
other large cities (300 000 or more residents). 
Frequently, the largest city in a country is also the 
capital city and it is on these cities that this paper 
primarily focuses, while also touching on examples from 
other cities. Qualitative data from the three sources 
were analysed and a documentary account of the key 
issues was generated, forming the basis of this paper.
(1) Information about the Reitox network can be found on the 
EMCDDA website.
Data sources
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which they occur (Bless et al., 1995). Nonetheless, such 
scenes have certain characteristics in common. These can 
include the presence of polydrug use (often involving heroin, 
prescription medications and alcohol), public health issues 
linked to injecting drug use (infection with HIV and hepatitis B 
and C viruses) and the presence of congregations of drug 
users and the accompanying problems this often raises 
(criminality, public nuisance). The term ‘open drug scene’ is 
often used to describe this phenomenon, and a useful and 
overarching definition has been provided by Bless et al. 
(1995), who view open drug scenes as ‘all situations, where 
citizens are publicly confronted with drug users and drug 
dealing’. In the present study, open drug scenes were reported 
as existing in eight cities (Berlin, Brussels, Bucharest, 
Copenhagen, Dublin, Oslo, Paris and Prague) (see Figure 1).
I Outside: public spaces and open drug scenes
Modern cities are typically complex built environments that 
comprise a mixture of new and old areas consisting of various 
types of public and private spaces. Every city has certain 
spaces that are associated with drug use. Such spaces 
include nightlife locations, transit hubs, parks, squares, 
riverfronts, disused and derelict industrial and residential 
spaces, isolated alleys and areas marked by socioeconomic 
deprivation.
Historically, some of the more damaging forms of publicly 
visible drug use have been concentrated in cities. It is difficult 
to describe these open drug scenes as a whole, as they vary 
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railway stations (Paris North and Paris East), metro stations, 
parks and streets (between parked cars). In general, the health 
and living conditions of drug users in these open drug scenes 
have deteriorated (Cadet-Taïrou and Gandilhon, 2013; Pfau 
and Péquart, 2014).
In both Dublin and Berlin, the open drug scenes are more 
reflective of a dispersed model, with multiple small scenes 
present in the city centre. Neither city has any large-scale 
scene involving hundreds of users, although Berlin did up to 
the 1970s. In Dublin, the open drug scenes are focused on a 
riverside area and side streets and alleys near the city’s main 
thoroughfare, with users and dealers walking and cycling 
around the area and moving in response to police activity. In 
Bucharest, dispersed open drug scenes can be found in each 
of the city’s five districts. For example, in the city centre there 
are dispersed scenes focused around Herastrău Park and the 
Gara de Nord station. In Sector 5 of the city, such scenes can 
be found in the Ferentari area, for example, where the Carusel 
Association’s drop-in needle and syringe exchange service, 
the Caracuda Center, operates (Din, 2014).
Dispersed open drug scenes involving small numbers of users 
are also present in Brussels in the area stretching from 
Simonis Park to Ribaucourt and on to the Yser district. In this 
space, which extends along the metro line, drug use takes 
place on the street, in public toilets, in metro stations and in 
abandoned buildings; the drug users move around the area 
and shift from location to location. As in other cities, the open 
drug scenes here comprise both local users and migrants, as 
well as others commuting to the area from different places 
(Kirzin et al., 2012).
The open drug scenes found in European cities revolve around 
complex patterns of drug use involving multiple substances. 
While most scenes are primarily opioid-based, polydrug use 
involving multiple licit and illicit substances is the norm. For 
example, in Prague the open drug scene revolves around 
injecting methamphetamine (Pervitin) use, heroin use and use 
of diverted buprenorphine. The scenes found in Berlin and 
Copenhagen primarily involve injecting heroin users. In Dublin, 
a diverse range of substances have been available at different 
times in street-level drug scenes, alongside the use of alcohol. 
These include heroin, cannabis, new psychoactive drugs such 
as mephedrone, prescribed medications such as 
benzodiazepines, zopiclone (Zimovane) and diazepam 
(Valium), crack cocaine, methadone and crystal meth 
(Connolly, 2012; Van Hout and Bingham, 2013). Such a range 
of substances gives an indication of the shifting nature of the 
drug markets that supply these scenes. Products are sourced 
from multiple channels, including illicit drug dealers, thefts, 
diversion of prescribed medications and the Internet. Polydrug 
use also defines the open drug scenes in the Ribaucourt area 
of Brussels, where users with long polydrug-using histories 
(15 years or more) are found along with others who mainly use 
The open drug scenes found in European cities are a shifting 
and transient phenomenon, reflecting changes in drug use 
and drug markets. Most of the scenes active in the cities 
discussed here can be categorised as either ‘concentrated’ or 
‘dispersed’ open scenes (Bless et al., 1995). A major 
difference between these two types is the number of users 
present, with concentrated scenes typically containing large 
gatherings, sometimes up to hundreds of users. In a dispersed 
scene, there are more gatherings, but each contains fewer 
users, often as few as 10. Many cities’ open drug scenes move 
back and forth between both types and defy neat 
categorisation.
The evolution of the open drug scenes found in Prague 
provides an example of the changing nature of these drug-use 
settings. Concentrated open scenes involving opioid users 
used to exist in Wenceslas Square and Charles Square in the 
city centre, containing a population that fluctuated between 
300 and 500 problem drug users each day. However, the 
scene has moved from these areas to other locations, such as 
the Vrchlický Gardens, close to the main railway station, and 
the Smíchov district. In addition, smaller open drug scenes 
can also be found in several of the city’s districts. In Oslo, an 
open drug scene existed in the Karl Johans Gate area near the 
central station and Skippergata. However, following police 
interventions, the scene at the station was dispersed in 2012. 
Other scenes have subsequently developed close to the 
Akerselva River, near the Grünerløkka area, and in two other 
areas, Vaterland and Grønland. The changing nature of open 
drug scenes is also evident in Copenhagen. Focused on the 
Vesterbro area of the city, near the central station, the scene 
has existed since the 1970s. Its population consists of 1 000 
opioid users, including 500 regular users and another 500 
more occasional users. However, most of those frequenting 
the scene are not from the area and they commute there from 
other municipalities and countries, primarily Sweden.
The open drug scenes found in Paris also reflect the 
movement between and combination of concentrated and 
dispersed gatherings. In the 1990s, an open crack cocaine 
scene, comprising some large and many smaller gatherings, 
emerged in north-east Paris in the 18th arrondissement and 
was estimated as involving 6 000–8 000 users in 2008 
(Halfen and Vincelet, 2008). The visibility and geographical 
concentration of this scene has shifted at different times 
because of policing activities addressing squats and dealing 
areas (Halfen and Vincelet, 2008). An open drug scene also 
exists in the department of Seine-Saint-Denis, next to north-
east Paris. Crack cocaine smoking and heroin injecting 
predominate in these scenes, which are characterised by high 
levels of marginalisation among multi-ethnic, migrant drug 
users often experiencing homelessness (Halfen and Vincelet, 
2008). Following the dispersal of user gatherings and squats, 
an increase in high-risk drug use in public spaces within these 
areas has been observed since 2011, with users injecting in 
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Budapest and Paris, syringe-dispensing machines have also 
been used (Duplessy and Reynaud, 2014).
Data from needle and syringe exchange programmes can give 
an insight into both the level of injecting taking place and the 
level of service provision. In Madrid, 603 776 needles and 
syringes were dispensed in 2011 (the return rate is 76 %); in 
Oslo, 1 871 239 needles were provided in 2011. In 
Amsterdam, 153 600 needles were exchanged in 2010, 
representing a substantial drop from the peak of 1 082 880 
provided in 1993. Data from Paris show that its 34 syringe-
dispensing machines were used to distribute 362 000 
syringes in 2013. Distribution rose by 32 % between 2009 and 
2013 because of increased delivery through machines in the 
North Station area, which accounted for nearly two-thirds of 
deliveries (Metropolitan Mission for the Prevention of Risk 
Behaviour, 2013).
Harm reduction services in certain cities also offer aluminium 
foil, acid, filters and sterilised cups. The provision of foil has 
been used in the project ‘Smoke It!’ (Berlin, Bielefeld, 
Dortmund, Frankfurt and Hamburg) as a tool to help 
discourage injection (Stöver and Schäffer, 2014).
Drug consumption facilities provide a supervised environment 
for drug use, usually injection. Such initiatives aim to reach 
marginalised users, drawing them towards other support 
services and preventing overdoses and the transmission of 
blood-borne viruses (HIV, hepatitis B and C viruses). This type 
of facility is currently offered in several German, Dutch and 
Spanish cities, as well as in Copenhagen, Luxembourg city 
and Oslo. In Berlin, Fixpunkt operates two fixed-site injection 
rooms and a mobile unit is operated as a flexible response to 
the shifting and transient nature of problem drug-using 
scenes at street level. In Barcelona, a reduction in the number 
of syringes disposed of unsafely in the area adjacent to the 
drug consumption facility was observed, with the monthly 
average dropping from 13 132 in 2004 to 3 190 in 2012 
(Vecino et al., 2013).
Naloxone, an opioid antagonist, can also be used to prevent 
overdoses. The availability and accessibility of naloxone varies 
from country to country. In some of the countries where 
naloxone is available, access may be through emergency 
services and hospitals only, whereas in other countries it is 
provided through drug treatment services and peers. A 
naloxone nasal spray, which removes the need to use a 
syringe, is being tested as an overdose response in the 
Norwegian cities of Bergen and Oslo (Clausen, 2014).
Reducing drug-related litter, such as discarded needles, is a 
challenge in many places. Municipal authorities are often 
responsible for collecting and disposing of drug waste under 
their legal responsibility for keeping public spaces clean. In 
practice, this task is divided between city services and private 
(inject or smoke) opioids (heroin, methadone) and cocaine 
(Kirzin et al., 2012).
I  City-level responses to problem drug use and open drug scenes
European countries have been converging on a core set of 
drugs policy options aimed at reducing harms for many years 
(Bergeron and Griffiths, 2005). Among the central features of 
drug treatment systems that have spread among European 
cities is the provision of opioid substitution treatment 
(methadone, buprenorphine) and access to needle and 
syringe exchange programmes (EMCDDA, 2013c; Klingemann, 
1999). Although cities vary in the provision of access to these 
services and in their geographical coverage, they are available 
in all cities.
Low-threshold service delivery is a well-established means of 
providing interventions to hard-to-reach and marginalised 
drug-using clients. At city level, it is one of the main modalities 
for responding to open drug scenes. Low-threshold agencies 
sometimes provide emergency shelter, clothing and food. 
Other services provided to drug-using clients may include 
counselling and other psychosocial support, harm reduction 
advice, drop-in centres and outreach teams. In most contexts, 
this range of services is an assemblage of municipal activities 
and activities run by non-governmental organisations (NGOs).
In Paris, the Metropolitan Mission for the Prevention of Risk 
Behaviour (Mission métropolitaine de prévention des 
conduites à risques) provides a range of services to high-risk 
drug users involved in open drug scenes. For example, it offers 
a mediation service between drug users, the public, 
businesses and city services. Through this activity, they seek 
to inform concerned stakeholders and contribute to the 
development of appropriate policies and interventions. The 
Mission also monitors areas where there are squats, in order 
to provide occupants with social support, and works with 
users to address antisocial behaviour that generates conflict 
with local residents (Metropolitan Mission for the Prevention 
of Risk Behaviour, 2014).
Various models for the provision of needle and syringe 
exchange programmes exist in Europe, and this service is 
provided in a range of low-threshold settings in cities (Cadet-
Taïrou and Dambélé, 2014; Cox and Robinson, 2008). These 
include fixed-site locations — such as drug treatment centres 
and drop-in centres, as in Bucharest and Paris — street-based 
needle and syringe exchange programmes, as in Budapest 
and Paris, and mobile units that may provide access also to 
substitution treatment. Such mobile services are active, for 
example, in Berlin, Copenhagen, Dublin, Helsinki, Lisbon, 
Madrid, Oslo, Paris, Riga and Vilnius. In some cities, such as 
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such as needles and foil in public places. Similarly, loitering, 
aggressive drug-fuelled behaviour, acquisitive crime and 
organised begging can erode the welcoming and safe 
atmosphere that cities strive to create for residents and 
visitors. Responding to these problems places costs on the 
local police, as well as city councils and local businesses, 
which must pay to clean areas affected by discarded drug 
waste. In some cities, such as Dublin, this has proved to be a 
persistent problem: 11 600 syringes were collected from the 
city’s streets in 2014 by the city council and other agencies 
(Fagan, 2015). 
The tendency to centralise services in inner cities has been 
driven by several factors, but it has resulted in many users 
converging on certain areas. Community-level resistance to 
the location of treatment facilities, commonly referred to as 
Nimbyism (‘not in my back yard’), has curtailed the options 
available to drug services when trying to attain geographical 
coverage and accessibility.
When services change, so do the drug scenes they are serving 
or that are clustered around them. In Prague, when a physician 
involved in the prescription of opioid substitution medication 
moved premises from one part of the city to another, the open 
drug scene moved with the clinic. Responses to the problems 
posed by open drug scenes in Prague have been hindered by 
local community tensions, resulting in the scenes being 
pushed from one area to another. In Oslo, debates have arisen 
around policing responses involving drug users being moved 
on, as this was seen as simply shifting the problem from one 
area to another.
I Businesses and recreational drug use
Cities often have a high density of premises where 
psychoactive substances are sold and consumed. These can 
range from licensed outlets for the sale and consumption of 
alcohol (off-licences, bars, music venues) to shops selling 
cannabis or new psychoactive substances. Many nightlife 
venues are sites where illicit drugs are also sold, whether 
inside or nearby, and consumed. Frequently, cities have 
specific areas where many of these businesses are clustered 
together. This gives rise to certain areas being characterised 
as places where drug use and intoxication are permitted, as 
well as informally designated zones where such behaviours 
are at least tolerated, if not accepted. While the specific 
configuration of these areas varies from city to city, they are 
places where various forms of drug use are intertwined and 
mingle with a range of recreational activities and cultural 
practices. Such nightlife areas present the different 
stakeholders involved in city-level drugs policy with a complex 
situation to manage. 
operators, which may be funded by local businesses to clean 
particular areas. This is the case in Dublin, where the city 
council has adopted a policy on the collection and safe 
disposal of needles (Cox and Robinson, 2008). In the United 
Kingdom, guidance has been issued on responding to drug-
related litter, providing city and town authorities with advice 
on developing plans to manage the problem (Department of 
Environment, Food and Rural Affairs, 2005).
Several responses other than mobile units are used at city 
level to respond to transient open drug scenes and drug-
related litter. For example, so-called sharps bins may be 
strategically placed in locations where users are known to 
inject. This allows for the safe collection and disposal of the 
waste (Parkin and Coomber, 2011). These measures are, for 
example, used in all large French cities, with Paris having 27 
syringe exchange machines in 16 of the city’s 20 districts. 
Methods aimed at deterring injection in public spaces include 
the use of fluorescent lighting; however, evaluations of this 
type of intervention have shown mixed results (Parkin and 
Coomber, 2010).
Open drug scenes and other areas affected by problem drug 
use have benefited in some cities from structural alterations 
to the built environment. This approach involves remodelling of 
urban areas that have structural features that have been 
identified by urban planners as enabling public drug use. In 
London, for example, an open drug scene existed in the King’s 
Cross area. However, following redevelopment of the area, 
public drug use was significantly reduced and a displacement 
of the problem was not documented (Young et al., 2006). 
Similar alterations to the built environment in Lisbon resulted 
in open drug scenes and drug markets in areas such as Casal 
Ventoso being brought to an end (Waal et al., 2011, 2014). 
Such environmental management approaches are successful 
only when a range of other measures and support services for 
drug users are simultaneously deployed. Otherwise, the 
problems are simply displaced, as initially happened in Zurich 
when the demolition of a number of buildings where squatting 
was commonplace resulted in the movement of the drug 
scene to the Platzspitz Park (Bless et al., 1995).
Open drug scenes are often located in parks and close to 
railway stations, as in Paris, but they can also form near drug 
treatment settings, as seen, for example, in Prague and Dublin 
(Van Hout and Bingham, 2013). Sometimes services follow 
users and are located near where these scenes have settled, 
as in Copenhagen and Oslo. Changing the location of services 
has an impact on open drug scenes and its successful 
implementation is dependent on careful multistakeholder 
strategic planning.
Cities with open drug scenes that revolve around injecting use 
of opioids and other drugs face significant public nuisance. An 
example of this is the unsafe disposal of drug paraphernalia 
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implemented in nightlife and nightclub environments in 
Europe (EMCDDA, 2014c).
Information campaigns aimed at educating club-goers about 
the risks of drug use are present in some cities. Other 
measures, which go further in their attempts to reduce 
drug-related harms, can also be identified. In Amsterdam, an 
action plan was established targeting club-goers using GHB. 
Among the elements included in the plan were a public 
information campaign addressing the users, training for staff 
in key settings and the provision of low-threshold care 
services. Among the more targeted interventions reported in 
European cities is the provision of ‘pill-testing’ services 
(sometimes in nightclubs or at festivals), allowing users to 
obtain a chemical analysis of tablets or powders. This service 
has been available in several cities, including Amsterdam, 
Berlin, Paris and Zurich, at various times (Benschop et al., 
2002; Hungerbuehler et al., 2011). In Vienna, the ‘Check it!’ 
service has been operational since 1997 and provides 
information on the risks of taking drugs. It also offers users 
chemical analysis of their substances, a service which is free 
and anonymous. Similar services are also available in Madrid 
and other Spanish cities.
While established prevention and harm reduction measures 
exist for recreational drug-using contexts, the environments 
for delivering them are complex and subject to change. For 
example, in Amsterdam some electronic music events are 
organised in changing locations at short notice and largely 
through social media. This practice has emerged in response 
to the commercialism of some clubs on the one hand and 
stricter enforcement of anti-drugs policies at city level on the 
other hand. The transient nature of these parties and the use 
of the Internet to advertise them at short notice through 
networks of interested club-goers make the events difficult for 
prevention workers to identify and attend without being 
notified. Other cities, such as Berlin, also have established 
venues and ad hoc locations, both hosting events for 
club-goers. 
Problem consumption of alcohol is common in various 
nightlife environments, and European cities have adopted 
different measures to respond to it. Madrid has established a 
mobile programme, ‘Are you going out today?’, aimed at 
educating young people going to nightlife areas about the 
risks of drug use. The Autonomous Community of Madrid, in 
which the city is located, has also established an ordinance 
that makes the consumption and sale of alcohol on the street 
illegal. The Noise and Heat Pollution Protection Ordinance of 
2011 establishes that street drinking is in contravention of the 
Region of Madrid’s Law on Drug Dependencies and Other 
Addictive Disorders. In Vienna, the ‘Party Fit!’ project aims to 
prevent and reduce problem drinking among young people. 
The programme is implemented at large events, using a 
peer-to-peer method. In Denmark, a project involving 20 
Modern cities provide multiple opportunities and contexts for 
recreational drug use. All of the cities looked at in this paper 
have extensive nightlife zones where recreational drug use 
takes place. These areas have a large number of retail outlets 
for the sale of alcohol (bars, off-licences), as well as nightclubs 
and various venues where music-related events take place. 
This creates a situation where parts of the city experience a 
significant increase in the number of people using drugs in the 
evenings and at weekends.
Recreational drug use has consistently been associated with 
nightlife, music events and, most prominently, the electronic 
music clubbing scene (Chinet et al., 2007; Tossmann et al., 
2001; Van Havere et al., 2011; Winstock et al., 2001). A study 
in Belgium found that drug use, while being more common in 
dance music venues, was reported in all nightlife venues, 
irrespective of music style, as well as in bars (Van Havere et 
al., 2011).
Studies covering Amsterdam, Budapest and Copenhagen, for 
example, have shown that a wide range of substances may be 
used in nightclub settings in European cities, including 
alcohol, prescription medicines, cannabis, new psychoactive 
substances, ecstasy, cocaine and amphetamines (Benschop 
et al., 2011; Csák, 2012; Järvinen et al., 2010). Research in 
London nightclubs has shown the existence of a complex 
relationship between established drugs, such as ecstasy and 
cocaine, and new psychoactive substances, such as 
mephedrone; the latter tend to be used as a supplementary 
drug rather than as a replacement substance (Moore et al., 
2013). Responding to problems relating to the use of these 
substances may be complicated by the fact that the users 
often do not know what substance they have consumed 
(Measham and Moore, 2011). A study covering Bordeaux, 
Metz, Nice, Rennes and Toulouse looked at drug use among 
participants in the electro party scene. It found a high 
frequency of cocaine and ecstasy use, as well as daily 
cannabis use (Reynaud-Maurupt and Cadet-Taïrou, 2007).
Cities often contain different zones where recreational drug 
use takes place. In many cities this includes tourist-oriented 
zones, where public intoxication is tolerated. Many groups of 
foreign tourists will go to bars and clubs in these areas. These 
sites are where alcohol-fuelled, so-called hen and stag parties 
take place (Eldridge and Roberts, 2008; Lancial and Lose, 
2013). Dublin, Lille and Prague, for example, have nightlife 
areas where such events are common.
I Interventions in recreational settings
Various measures have been developed to respond to licit and 
illicit drug use in nightlife settings. Among the interventions 
are selected prevention strategies targeting the club-going 
population. These measures are not, however, widely 
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(EMCDDA and Europol, 2013). In countries where new 
psychoactive substances were sold in street-based retail 
outlets, in many cases these shops were located in cities near 
nightlife areas, although they have also been located in 
suburban and rural towns in some countries, such as Ireland 
and Poland.
Around Europe these shops have been known by a variety of 
names, including head shops, smart shops, Amsterdam 
shops, weed shops and euphoria shops. A variety of different 
psychoactive substances have been sold in these shops since 
the start of the century, such as hallucinogenic mushrooms 
(psilocybin, fly agaric) and plants (salvia) and a multitude of 
synthetic substances marketed as alternatives to illicit drugs 
such as cannabis and amphetamines (EMCDDA, 2006). Some 
of these products — such as ‘Spice’, a brand name used for 
various synthetic cannabinoids, and various synthetic 
cathinones, for example mephedrone — became popular 
among groups of drug users (EMCDDA, 2009; Van Hout and 
Brennan, 2011b). For example, the use of synthetic cathinones 
has been reported among diverse groups, including those who 
inject heroin looking for replacements in times of shortage, 
men who have sex with men at ‘slamming parties’ and 
clubbers using the drug recreationally (EMCDDA, 2014d; 
Stuart, 2013; Van Hout and Bingham, 2012; Van Hout and 
Brennan, 2011a, 2012).
Nine cities (Amsterdam, Berlin, Bratislava, Bucharest, Dublin, 
Lisbon, Madrid, Riga and Warsaw) reported that street-based 
shops which had been selling new psychoactive substances 
in the past either had been closed or no longer stocked new 
psychoactive substances. In all cases, the closure of the 
shops or removal of the products was driven by legislative 
measures (EMCDDA, 2014e; Hughes and Winstock, 2012). 
While national legislation has been the main tool used to 
respond to the challenge posed by new psychoactive 
substances, the impetus for its alteration and use has, in 
several countries, come from city level, as this is where the 
problems were most intense. This observation underlines the 
importance of the city as a site where drug issues arise and 
where the drive for solutions originates before diffusing 
nationally. In Amsterdam, there were roughly 25 active ‘smart 
shops’ in the city centre in 2012. Many stores closed following 
a ban on the sale of dried mushrooms in 2008; the remaining 
ones sell truffles (sclerotia) called ‘philosopher’s stones’, which 
contain psilocybin, as well as cannabis seeds. The truffles are 
legal because they are not a prepared product, in contrast to 
dried ‘magic mushrooms’. This, like the frequent changing of 
the molecular basis of new psychoactive substances in 
response to the law, shows the difficulties of closing all 
loopholes when the option of prohibiting sale is pursued.
In some European cities, it is possible to obtain cannabis from 
outlets other than the illicit drugs market. The Netherlands 
differs from other EU Member States in its attempts to 
municipalities was launched in 2009; it aimed to institute 
responsible serving of alcohol. This resulted in training 
courses being offered by the municipalities to those who serve 
alcohol. In Vilnius, a competition was organised by the police 
to select ‘the safest night bar’. It involved a survey of late-
opening bars and the number of offences and problems 
reported on the premises or nearby. The shortlist of winners 
was intended to promote these businesses and underline 
examples of best practice in operating venues.
Measures to prevent and reduce alcohol-related harms aimed 
at both patrons and staff in nightlife venues have been 
implemented in French cities. In Marseille and Paris, 
information materials on prevention, risk reduction and health 
consequences arising from alcohol use are available for 
dissemination in entertainment settings. In Bordeaux, 
breathalyser terminals have been installed in some clubs as a 
risk reduction measure. Mobile chill-out spaces where 
prevention and risk reduction information is provided have 
been deployed in Paris by the city authorities, and mobile 
teams work at times when they can reach club- and party-
goers (such as 22:00–02:00). In Marseille, late-night bus 
transportation has been timed to match the opening hours of 
party venues. Multi-city initiatives have also been undertaken 
in Europe to address alcohol use. For example, a project 
involving Antwerp, Bordeaux, Brest, Kingston upon Thames, 
Liege, Nantes, La Rochelle, Reggio Emilia, Rotterdam and 
Stuttgart, led by the French Forum for Urban Security (FFSU) 
and the European Forum for Urban Security (EFUS), looked at 
the issue of excessive alcohol consumption (FFSU and EFUS, 
2013). It focused on the areas, events and public spaces 
where alcohol is consumed and aimed to strengthen the 
security of such spaces and foster responsible consumption 
of alcohol.
Drinkers and recreational drug users may account for a 
substantial share of drug-related public nuisance. For 
example, excessive drinking by tourists and locals creates 
social and environmental problems for residents in cities with 
nightlife settings. The complexity of this issue is clear, 
however, when it is considered that the presence of 
consumers, including recreational drug users, in bars and 
clubs provides a source of revenue for some local businesses. 
It is also apparent that the financial burden of responding to 
the health problems that emerge in the short and long term 
from these drug-using scenes is placed on municipal and 
state budgets, the local community and businesses.
I Smart shops and coffee shops
The retail sale of new psychoactive substances is a complex 
problem, as the trade is carried out through physical outlets 
and street-level dealing, as well as through surface (visible to 
all users) and deep (anonymised, encrypted) websites 
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The presence of publicly visible drug problems puts pressure 
on those who are responsible for and those with an interest in 
the running of cities. Certain urban environments can be 
conducive to drug dealing, including networks of alleys, 
recessed doorways and loading bays, busy shopping streets 
and bus and rail terminals. Closed-circuit television systems 
are sometimes used by the police and businesses to manage 
open drug scenes and target street-level dealing. For example, 
in Dublin these systems are used to observe activity and 
support police actions in areas where open drug scenes exist 
and dealing occurs.
Frequently, by-laws or local-level legal instruments such as 
ordinances are used to address issues such as loitering and 
street drinking. One example is the use of antisocial behaviour 
orders, through which drug users can be ordered to leave and 
remain outside of an area associated with drug use and 
dealing. Amsterdam, like other cities such as Prague, has 
experienced problems with fake drug dealers targeting 
tourists as a pretext for robbery (29 % of the drug-related 
incidents registered in Amsterdam between 2005 and 2009 
were related to thefts of this kind). In response, a by-law was 
enacted in October 2009 designating key spaces as nuisance 
areas that individuals such as drug dealers can be banned 
from entering. While not without problems, such as the 
‘balloon effect’ of pushing the activities to adjacent locations, 
this measure is ongoing and supported by active enforcement 
and communications directed at tourists.
Responding to street-level drug dealing can be a priority for 
city police forces and is a standard feature in their strategic 
planning. Around Europe, city-level policing strategies actively 
address the security challenges posed by open drug scenes. 
For example, Amsterdam’s Security Plan seeks to address 
drug-related crime and public nuisance in the city and utilises 
a wide range of measures from social support to barring 
orders and urban regeneration. In Warsaw, drug-related crime 
is targeted in the Crime Prevention Strategy 2011–2014, while 
in Oslo the police’s Plan for City Centre Work 2012–2015 
seeks to address a range of drug problems, such as open 
drug scenes.
Active cooperation and coordination between those involved 
is critical in addressing city-level drug problems. Around 
Europe, police forces work with those providing health 
services to drug users, such as treatment and low-threshold 
agencies, to achieve shared objectives. In Copenhagen, the 
police and social service providers have improved their 
cooperation in recent years in order to better address drug 
problems. Local policing forums exist throughout Ireland and 
are present in the capital city, Dublin. These structures include 
representatives of the police, local drugs and alcohol task 
forces, local authorities and community representatives, and 
they address problems linked to drug use (Connolly, 2006a). 
The Strategic Response Group initiative was established in 
separate the hard and soft drug markets. Chief among these is 
the policy of tolerance towards retail stores for the sale of 
cannabis (known locally as ‘coffee shops’), introduced with 
the rescheduling of cannabis in the 1976 narcotics law the 
Opium Act and in local guidelines in 1979. The policy 
governing coffee shops provides a set of minimum criteria that 
can be expanded by municipalities, most of which have their 
own coffee shop policies (EMCDDA, 2014f).
In December 2011, there were 651 coffee shops in the 
Netherlands. Just under half of the shops are based in the 
large cities of Amsterdam, Rotterdam and The Hague. In 
Amsterdam, for example, there are 140 cannabis coffee shops 
in the city’s central borough. They are visited by roughly one 
quarter of all tourists coming to the city, or about half a million 
people each year, in addition to local customers. This creates a 
situation where some residents and others in the city may 
experience drug-related public nuisance from the shops’ 
customers. In Rotterdam, following the closure of 18 coffee 
shops located near schools from 2009 onwards, there was a 
significant decrease in public nuisance incidents being 
reported by residents to the police. There was also a lower 
level of nuisance experienced (not necessarily reported) by 
residents, in terms of the elimination of traffic to and from the 
shops and fewer street-based dealers as a result of an 
increased police presence. As with bars and clubs, customer 
traffic is one of the consequences arising from allowing these 
businesses to exist; others include the drug-related public 
nuisance that is prevented and the separation of the hard and 
soft drug markets.
However, public nuisance from coffee shops also takes other 
forms. Cannabis sold in the shops must be cultivated and 
produced. Under the Dutch Opium Act, a loophole (the 
‘backdoor problem’) exists for coffee shops, which are not 
licensed or allowed to import or cultivate cannabis. As a result, 
the drug is acquired from illegal sources. In 2009, 310 
cultivation sites containing 98 914 plants were dismantled in 
Amsterdam. Poorly managed sites can pose various hazards 
to the public, for example, from electrical faults and fires, the 
illegal use of electricity sources and structural damage to 
rented properties.
I Security and public spaces
In all cities, a policy mix exists between responses addressing 
public health issues and those aimed at ensuring the safety of 
urban areas (Bless et al., 1995). Various stakeholders, 
including city authorities, local courts, police and businesses, 
are responsible for protecting and maintaining a safe 
environment. To this end, a number of different strategies are 
widely used in European cities.
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among young people and is one of the tools the city uses to 
monitor drug use. The Metropolitan Mission for the Prevention 
of Risk Behaviour, in partnership with the French Monitoring 
Centre for Drugs and Drug Addiction (OFDT), undertakes 
similar work through the ESCAPAD survey. It is used to take 
regular snapshots of drug use among young people (Beck et 
al., 2005; Legleye et al., 2008; Spilka et al., 2010).
Other approaches are also used to gain insights into local drug 
problems, including rapid assessment research methods 
(Connolly, 2012; Van Hout and Bingham, 2013). An emerging 
method in the field of drug epidemiology is wastewater 
analysis. This technique has been spearheaded by a network 
operating at city level around Europe and has the potential to 
become an important element in monitoring drug use trends 
(EMCDDA, 2014h).
Both policymakers and those tasked with providing responses 
at street level rely on the insights that can be derived from 
monitoring data. One of the challenges in this context at city 
level is the need for reporting systems to produce data in a 
more timely way. This is crucial for effectively designing and 
targeting responses, given the range of drugs now used in 
local drug scenes and the speed with which new substances 
can emerge, bringing with them new risks. City-level 
monitoring systems provide an opportunity to gather up-to-
date information on drug trends and contribute to a more 
strategic use of resources and targeting of responses.
I City-level drugs policies
The development of drugs policy at various levels, 
international, national and local, is shaped by the type of drug 
problems being experienced and the actions of those who 
respond to them. Policies take a different shape from country 
to country and city to city, but they are all constructed through 
a policy process involving multiple stakeholders with different 
views (EMCDDA, 2011, 2013b, 2014b, 2014g; Hill, 1997). One 
result of this is that problems are defined and responses set 
out in strategic planning documents. It is in these drugs 
strategy documents that we can find some of the main 
principles, priorities, objectives, actions and actors in the 
official response to drug issues. While the adoption of drugs 
strategies at national level has become a standard feature of 
the public administrative response to drug problems in Europe 
(EMCDDA, 2014c), a more unclear and complex situation 
exists at city level (see box ‘Defining city-level drugs policy’). 
This section of the paper takes a look at the presence and type 
of strategy documents in a selection of European cities.
Dublin in 2011. This cooperation mechanism, which involved 
the police, local businesses and drug services, was focused 
on the delivery of services to drug users and reducing public 
nuisance (Connolly, 2012). The Vienna Addiction Service’s 
‘Security, Activity, Mobility’ strategy also seeks to address 
drug problems in the city by targeting issues relating to public 
spaces. Three teams work with drug users to connect them 
with addiction and social services. The Community Drug 
Dependencies Mediation Programme in the city of Madrid 
aims to reduce conflicts arising from the presence of drug 
users in public spaces by working with the users, local 
residents and business people. In 2011, the programme was 
implemented permanently in eight areas of the city and on a 
targeted basis in two others.
I City-level data for policy and provision
Every city has in place a range of administrative systems that 
can be used to describe and monitor drug problems. For 
example, drug treatment data, hospital emergency records 
and police records can all provide insights into levels of drug 
use. However, collecting these data and unlocking the picture 
they hold is not an easy task, particularly where routine access 
for drug monitoring is not available. In several cases, national-
level monitoring systems have their origins in city-level 
epidemiology. The Pompidou Group of the Council of Europe 
organised some of the first multi-city studies on drug use, 
which highlighted the potential of local data to yield policy-
relevant information (Bless, 2000; Hartnoll, 1994; O’Hare et 
al., 1987).
Some cities have dedicated local drug monitoring systems, 
while others use various ongoing and ad hoc methods to 
monitor drug use. Around Europe, several local drug 
monitoring systems are currently in operation at city level. 
These include Antenna in Amsterdam, the Føre Var system in 
Bergen, MoySD in Frankfurt and the Trend system in seven 
French cities (Bordeaux, Lille, Marseille, Metz, Paris, Rennes 
and Toulouse). The systems operate on a number of different 
models, comprising a mixture of approaches involving 
indicators, surveys, experts and panels. These types of 
systems often use triangulation (results from several sources) 
to validate their results (Mounteney et al., 2010). Such 
systems have the ability to combine information from 
sensitive or ‘leading edge’ indicators (e.g. key informants) with 
that from ‘time-lagged’ ones (organisational systems) (Griffiths 
et al., 2000; Mounteney and Leirvåg, 2004). The National 
Bureau for Drug Prevention in Poland works with cities to 
develop local monitoring capacity. It provides training and 
networking for administrators in roughly 200 communes that 
monitor local drug situations.
Surveys are often used to provide insights into drug use. In 
Stockholm, for example, a biannual survey is undertaken 
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Countries within the European Union vary dramatically by 
population, from 82 million inhabitants in Germany to 
0.42 million in Malta. Some contain many large cities (of at 
least 300 000 inhabitants), and some cities have populations 
greater than some entire countries. These demographic 
variations bring with them differing needs for strategic 
planning in the drugs policy area. Around Europe, cities vary in 
terms of how they set out their drugs policies (see Figure 2).
Many European cities have had an official drugs strategy 
document at one time or another. This study found ten capital 
cities (Berlin, Bucharest, Copenhagen, Helsinki, Lisbon, 
Madrid, Prague, Stockholm, Vienna and Warsaw) with a 
strategy document that could be considered currently active. 
This was the most common approach to expressing city-level 
drugs policy. A strategy may be accompanied by an action 
plan, which sets out the details of the measures to be taken. In 
some large cities, such as Budapest, Bucharest and 
Drugs policies can be developed and implemented at 
different levels of administration, from the international 
and regional to the national, provincial, local and 
municipal. A city-level policy can be defined as the 
measures taken by local policy actors to address all or 
some aspects of drug problems in a specific urban 
location. These policies can mirror or depart from the 
concerns of national ones. Such policies are commonly, 
but not always, expressed in the form of unified or 
separate issue-specific strategy documents. They can 
also be found in key reports on drug problems, which 
may not be officially endorsed documents. City policies 
are subject to varying degrees of coordination and 
cross-sector stakeholder involvement.
Defining city-level drugs policy
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strategic plan addressing crack use that, as part of an 
approach designed to promote access to care, called for the 
use of transitional accommodation for homeless crack users. 
In other cities, issue-specific expressions of policy and 
attempts to influence it can be found in different types of 
documents. These include specific state-of-play research 
reports or strategy documents that have come from a level 
below the municipal authorities. Both types of strategic 
documents have been used in relation to crack cocaine in 
London and Paris, and crack cocaine and substance misuse 
and antisocial behaviour in Dublin (Connolly et al., 2008; 
Greater London Alcohol and Drug Alliance, 2004; Jamoulle 
and Fournie, 2007). 
Other means of expressing city-level drugs policy can be 
found around Europe. These include the inclusion of key 
issues in other city-level strategic documents, which 
ultimately function as reference points for those working in 
the drugs area. This approach is evident in both Riga and 
Vilnius in the north-east of Europe. In Vilnius, the 2012 
Socialisation Programme for Children and Youth, as well as 
the 2012 Healthcare Protection Programme, implements a 
range of prevention and drug treatment measures. The main 
strategy document addressing addiction in Riga is the Public 
Health Strategy ‘A healthy Rigan in a healthy Riga’ for 2012–
2021. It makes provision for addressing prevention and harm 
reduction issues. As well as having issue-specific strategies, 
Brussels also addresses drug problems through the city’s 
policing plan Le Plan zonal de sécurité Bruxelles Capitale.
Throughout Europe, most countries’ national drugs strategies 
are complemented by supporting documents at regional and 
local levels. While the district division encompassed within a 
local drugs policy area may include a city located there, these 
strategies are typically focused on a wider area, not just the 
city. Nonetheless, such documents provide a useful source of 
direction for city-level policy when there is no major difference 
between the types of problems and responses being 
addressed at the subnational level and in the city. 
Consequently, several cities around Europe, including Ankara, 
Bratislava and Budapest, have adopted this as the primary 
model for expressing their drugs policies. In the United  
Kingdom, for example, the strategies of drug and alcohol 
teams often cover cities and the surrounding regions.
Nearly all city-level strategy documents have been developed 
in collaboration with a range of stakeholders. These 
documents represent the outcome of a multidisciplinary 
consultation process that seeks to provide a means for 
concerned policy actors to have a voice in the design of policy 
and its expression in strategy. In this respect, developments at 
city level reflect trends in much of Europe’s strategic planning 
at both EU and national levels, where key features of ‘new 
public management’ are evident in the use of such documents 
and open consultation processes are used in their creation.
Stockholm, individual districts have their own action plans 
aimed at implementing the city’s strategy.
In many cases, city-level drugs strategies have a similar focus 
and structure to the documents adopted by the region and 
country in which the city is located (1). Stockholm’s Tobacco, 
Alcohol and Narcotics programme reflects the concerns and 
scope of Sweden’s national and regional strategies. It is 
primarily aimed at helping people to live a drug-free lifestyle, 
use alcohol moderately in adulthood and seek treatment when 
necessary. Helsinki’s 2000 drugs strategy does not have a 
defined time frame and mirrors the focus of Finland’s 1997 
national drugs policy document on a range of harms, including 
drug-related deaths, infectious diseases and crime. Since 
1990, Lisbon has adopted a number of city-level and issue-
specific strategies, which reflect the principles and approach 
of national policy. In 2006, for example, Lisbon City Council 
adopted the Municipal Intervention Strategy for Addiction, 
which addresses both addiction and social exclusion. 
Warsaw’s drugs strategy aims to reduce the prevalence of 
drug use and its harms, as does its national-level counterpart, 
through treatment, harm reduction and rehabilitation, as well 
as post-rehabilitation care and the provision of social welfare. 
While Austria does not have a federal-level drugs strategy 
document, the principles and approach of its drugs policy are 
found in its legislation, for example in the Narcotic Substances 
Act (EMCDDA, 2014a). Vienna’s drugs policy reflects this; the 
city’s strategy document was originally adopted in 1999 and 
updated in 2013. The Addiction and Drug Strategy takes an 
integrated approach and addresses behavioural addictions 
and licit and illicit drugs. Similarly, Berlin’s programme for 
combating drug abuse has evolved since it was established in 
1977 to encompass illicit drugs, alcohol and other addictions. 
This is also the approach adopted in the Federal Strategy on 
Drug and Addiction Policy. Madrid’s Plan on Addictions 
2011–2016 builds on the city’s first drugs strategy, from 1988, 
and addresses prevention, treatment and community 
engagement, with a transversal focus on developing and 
ensuring quality service provision.
In several cities, drugs policy is expressed in a more thematic 
way. This approach can be seen in the use of issue-specific 
strategies, which are tightly focused on a key drugs policy 
issue. For example, Copenhagen (which also has a city 
strategy) and Oslo have strategies targeting open drug 
scenes, while Amsterdam has had individual strategies and 
coordinators covering issues such as coffee shops, nightlife 
and social relief for the homeless. Brussels also addresses 
drug problems through issue-specific strategies such as its 
harm reduction plan, Le plan Bruxellois de réduction des 
risques liés à l’usage de drogues. Similarly, Paris has a 2013 
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strategy evaluation only taking place to a limited extent at city 
level, in many cases assessments may be carried out at a 
higher administrative level.
I  Coordinating and funding city-level drugs policy
At city level, the complexities of delivering an effective 
response to drug problems come into focus. Here, a range of 
stakeholders are involved in providing services to address the 
various drug problems that are found in cities. Whether 
comprehensive policies like those found at national level or 
more issue-specific strategies are adopted, a variety of 
concerns spanning different policy fields and areas of activity 
are typically addressed. As a result, the formal arrangements 
put in place to coordinate those involved in implementing 
policy are important in delivering effective responses (see 
Figure 3). Singleton and Rubin (2014, p. 2) describe the 
governance of drugs policy as ‘the mechanisms, processes 
and structures through which policy is informed, made, 
implemented and assessed’. This section of the paper looks at 
some of the coordination arrangements, such as official 
structures and policy networks, found in European cities.
Generally, city authorities are formally responsible for the 
coordination of drugs policy in the municipality. In some 
cases, as in Helsinki, Madrid and Warsaw, this designated 
responsibility is established in law. Where city authorities are 
responsible for drug issues, they differ in terms of using either 
a dedicated drugs policy unit or a generic policy unit with a 
range of other responsibilities to manage their drugs strategy.
In Prague, the Drug Commission is a dedicated structure 
attached to the city council and is the main body responsible 
for drugs policy. Both Madrid’s Addiction Institute and 
Vienna’s SDW are specialised agencies connected to the city 
and are responsible for coordination. In Helsinki, two 
substance abuse prevention units, one for adolescents and 
one for adults, help coordinate the city’s response to drug 
problems. The Social Affairs Administration, which is part of 
the city authorities in Stockholm, is a dedicated structure 
responsible for drugs policy coordination. In Paris, the city 
authorities are responsible for drugs policy, and in 2013, 
together with the department of Seine-Saint-Denis, they 
established the Metropolitan Mission for the Prevention of 
Risk Behaviour. The Mission coordinates policy 
implementation in the areas of risk prevention and addictive 
behaviours (Metropolitan Mission for the Prevention of Risk 
Behaviour, 2014). In Brussels, the ultimate responsiblity for 
coordination of the policing plan rests with the office of the 
mayor. The harm reduction agency Modus Vivendi and the 
organisational networks Local Coordination on Drugs Brussels 
However, other features of this style of public administration, 
whereby business management concepts are used in the 
public service, are not prominent at city level. Chief among 
these is the use of evaluation as a standard component of 
strategy design. This stands in contrast to the situation at 
national level in Europe, where evaluation has become an 
established feature of national drugs strategies over the last 
decade, to the point that two-thirds of EU Member States have 
conducted evaluations (EMCDDA, 2013c).
A minority of cities had strategy documents that built in 
evaluation as a core element. However, in some cities the use 
of evaluation in a strategic planning style to judge and design 
strategies was evident. For example, Oslo’s first strategy on 
open drug scenes was subject to an evaluation in 2005, which 
found that the strategy had helped to improve service 
provision for drug users but had not dispersed the open drug 
scene. The evaluation was subsequently used in the design of 
the follow-up strategy on open drug scenes. Warsaw’s Drug 
Strategy 2012–2015 reflects the approach taken in large cities 
throughout Poland and builds in a range of indicators, 
specifying the actors who are to implement measures, time 
frames and target populations. In Stockholm, one of the city’s 
districts evaluated the prevention measures implemented 
under the Alcohol, Narcotics, Doping and Tobacco (ANDT) 
Strategy in 2011.
Other cities have established monitoring and evaluation 
practices covering the programmes and services they 
implement. While not constituting an evaluation of a city-level 
strategy document, the presence of this approach is indicative 
of the focus on quality service delivery and governance in the 
post new public management era (OECD, 2010). This trend is 
exemplified by Madrid’s approach to evaluation. The city’s 
Addictions Plan 2011–2016 places an emphasis on evaluation 
of the delivery of services. A system has been implemented by 
the Addiction Institute to monitor activities at different levels. 
This includes the use of large-scale information technology 
systems to manage an addiction registry, supervise the 
treatment provided through automated methadone 
dispensing and analyse prevention interventions by 
geolocation and category. The Integral Management Team at 
the Addiction Institute collects information from a range of 
tools, including a survey of drug service clients, a suggestions 
and complaints system, and treatment results. Vienna’s 
Addiction and Drug Coordination (SDW) utilises a dynamic 
documentation system (DOKU NEU) to assist with strategic 
planning and facilitate evaluation of the services offered to 
drug users. This system, like Madrid’s, functions as part of the 
city’s local monitoring system.
While formal evaluation is incorporated in city-level strategy 
documents only to a limited extent, evaluations of national-
level strategies and programmes frequently cover the 
activities taking place in key cities. Consequently, rather than 
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(CLDB) and the Brussels Federation of Institutions for Drug 
Addiction (FEDITO BXL) together form a coordination 
structure responsible for implementing the city’s harm 
reduction plan. In most cities, a social policy unit with a wide 
remit is used to coordinate drug issues. In London, the city 
authorities have responsibility for drugs policy, and the health 
team attached to the mayor’s office at the Greater London 
Authority is involved in coordination. Typically, such units are 
responsible for social affairs or welfare policy at the 
city council.
All cities have a range of responsibilities with regard to the 
development and implementation of drugs policy. Irrespective 
of whether dedicated structures have been established to 
facilitate this activity, city authorities are involved in multiple 
direct and indirect ways. In cities where no formal coordination 
structures exist at city level, other national-, regional- or 
local-level structures are ultimately responsible for 
implementing drugs strategies. This arrangement, where cities 
are covered by national-level policies or their local 
implementation structures, was found in Ankara, Bratislava, 
Bucharest and Dublin.
Senior civil servants often function as drug coordinators by 
default, as a consequence of their position and tasks. 
However, in some cities, designated drug coordinators have 
been appointed by the city authorities. Berlin, Prague, Vienna 
and Warsaw have an officially designated drug coordinator, 
while Amsterdam appoints several issue-specific civil servants 
as coordinators. In practice, coordination of city-level drugs 
policy and strategy implementation is a diverse task that 
involves actors from different levels of government, as well as 
various other private and voluntary sector groups and the 
general public.
It is at city level that some of the main problems arising from 
drug use can be most acutely felt. Over time, this has pushed 
various groups to mobilise and develop responses. Initially, 
this impetus may come from outside the city’s administrative 
authorities, only later gaining municipal support and 
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problems (EXASS Net) was set up to provide experience and 
assistance for cross-sectoral cooperation. Operating under 
the auspices of the Pompidou Group of the Council of Europe, 
EXASS helps to connect cities, as well as organisations and 
individuals, to share and develop best-practice responses to 
drug problems. In 2010, a number of European cities signed 
the Prague Declaration. It underlined the need for strategic 
drug planning at city level. The Vienna Declaration, also 
launched in 2010, called for evidence-based drugs polices 
and an end to the criminalisation of drug users. Similarly, in 
2013, the Athens Declaration drew attention to the 
importance of maintaining sufficiently resourced geographical 
coverage of harm reduction services in the context of 
economic austerity.
These developments reflect the increased opportunities for 
cities and service organisations to work together and build 
support for certain approaches on drug issues. Nonetheless, 
cities remain a site where ideologically charged and radically 
differing perspectives on what drug problems are and the 
responses to them should be are worked out between multiple 
stakeholders. This has far-reaching implications for policy and 
underscores the value of developing a shared strategy in 
unifying those involved, while highlighting the complex 
achievement that city-level drugs strategies are.
Structures and networks are one way in which policy actors 
come together to define and take action on drug issues. 
Access to financial resources plays a key role in animating and 
sustaining these structures and the work they support. 
Comprehensive information on public funding for the 
implementation of drug strategies, however, is rarely available 
at national level in Europe (EMCDDA, 2008, 2014c). This is 
also true at city level. In addition, many cities have active 
community and voluntary organisations that play a key role in 
the delivery of services such as treatment and harm reduction, 
often receiving a mixture of public and private funding. This 
makes the task of defining what a city-level budget for a drugs 
strategy might be, and estimating what has actually been 
spent, very difficult.
resourcing. There is a tradition of advocacy in the drugs policy 
area throughout Europe, and it is often organisations 
operating at the front line of service provision that have 
pushed for new measures to be implemented (EMCDDA, 
2013a; O’Shea, 2007). Local activism has a range of effects. In 
many cities, local communities have organised in opposition 
to the location of drug treatment facilities or needle and 
syringe exchanges in their area, a form of activism referred to 
as Nimbyism (not in my back yard) (Cusick and Kimber, 2007; 
Davidson and Howe, 2013; Tempalski et al., 2007). The 
dynamic tension that characterises agreement on drugs 
policies internationally and nationally is also evident at 
city level.
Whether formal coordination arrangements exist or not, 
stakeholders at city level have always organised themselves 
into policy networks. These structures have been present on a 
European scale and nationally. Such networks can be driven 
by ideological concerns about drug issues, the desire of 
authorities to engage civil society, and issue-driven concerns 
of business, the community and voluntary sectors, and the 
general public at local level.
In the early 1990s, support for more liberal drugs policies and 
the development of harm reduction practices, as well as for 
the prohibition of illicit drugs, was evident in European cities. 
For example, in 1990 civic leaders from the cities of 
Amsterdam, Frankfurt, Merseyside and Zurich came together 
to establish European Cities on Drug Policy (ECDP) (Stadt 
Frankfurt am Main, 1991). This pro-harm-reduction platform 
resulted in the Frankfurt resolution and drew attention to 
criticisms of existing policy while exploring what the way 
forward could be in responding to problem drug use. 
Reflecting a different perspective on many issues, European 
Cities Against Drugs (ECAD) was founded in 1994 with the 
signing of the Stockholm Resolution. It supported the 
international drug control system established through the UN 
drug conventions and the prohibition of illicit drugs. In some 
ways, debates at city level have mirrored some of the classic 
struggles at national level over what the response to illicit drug 
use should be.
Around Europe, cities have come together to develop policy 
and state their support for key issues through different 
networks and declarations (see Table 1). For example, two 
Democracy, Cities and Drugs projects were run between 2005 
and 2011 by a network of 300 European cities, with the 
support of the European Commission. The projects aimed to 
develop and share best practices on responding to drug 
issues at city level (Coppel, 2008; Leclercq, 2008; EFUS, 
2011). The projects also led to the development of the Nightlife 
Empowerment and Well-Being Network (NEW Net), involving 
various NGOs addressing health issues in recreational 
settings (Ventura et al., 2013). Similarly, in 2007, a European 
network of front-line stakeholders responding to drug 
TABLE 1
City-level policy milestones
1990 Frankfurt Resolution/European Cities on Drug Policy 
(ECDP)
1994 Stockholm Resolution/European Cities Against Drugs 
(ECAD)
2005 Democracy, Cities and Drugs Project 1 (2005–2007)
2007 EXASS Net
2008 Democracy, Cities and Drugs Project 2 (2008–2011)
2010 Prague Declaration 
Vienna Declaration
2013 Athens Declaration 
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different substance-using phenomena may harm some 
businesses and services, while others thrive on the profits. 
The multidimensional nature of city-level drug problems calls 
for integrated responses that are designed with the input and 
support of all stakeholders.
Given the presence of diverse risk environments within cities, 
understanding and using the structural features of these 
urban locations is central to reducing drug-related harms 
(Rhodes, 2009; Ventura et al., 2013). It is within the many 
settings and social contexts found in modern cities that 
different types of drug users negotiate and ‘script’ risk 
behaviours (Mayock, 2005; Ventura et al., 2013). The 
concentration and scale of different drug-using environments 
present in cities, whether they are associated with 
problematic or recreational use, often creates an impetus for 
action. This pressure to provide responses tends to move 
initially from front-line service providers and local businesses 
and communities to municipal policymakers.
In some cities, the use of substances in civic spaces has been 
associated with problems of public nuisance (Bless et al., 
1995; Connolly, 2006b). The term ‘drug-related public 
nuisance’ spans a set of activities ranging from street-based 
drug injecting to concentrations of alcohol-intoxicated patrons 
in the vicinity of nightlife venues (EMCDDA, 2005). Problems 
related to drug use, with varying public order and public health 
implications, are experienced by most cities. Indeed, the 
structural features of modern cities may facilitate drug use.
At city level, there is a range of policy and practice responses 
aimed at tackling a variety of drug-related situations. For 
example, Europe’s cities have adopted a set of now widely 
accepted treatment and harm reduction measures to deal 
with the more problematic forms of drug use, including 
injection. Among these measures are the provision of opioid 
substitution treatment and needle and syringe exchange 
schemes. In some cities, supervised drug consumption 
facilities are also provided, as a means to reduce injection-
related harms and drug overdose deaths.
As new drug problems often first emerge in large cities, these 
urban areas will continue to be drivers of change in defining 
what constitutes adequate responses to drug use. Likewise, 
the data that can be gathered on drug use at city level from 
various sources, such as hospital emergency data and 
wastewater analysis, offer the possibility of developing forms 
of monitoring that allow a more intimate and up-to-date view 
of the state of drug problems, old and new.
Strategic planning at city level is difficult because of the 
number of stakeholders and their diverse interests. 
A number of European capital cities have a dedicated budget 
attached to their drugs strategies. The available expenditure 
figures range from EUR 6.5 million annually in Berlin to 
EUR 29.4 million in Madrid in 2011. The variation between 
these amounts can be explained by the fact that they were 
used to fund specific measures by agencies used to 
implement the city strategy (Berlin) and to fund entire agencies
that play a key role in responding to drug issues (Madrid). 
 
Funds are allocated from different sources and in some cases 
as a result of a legal requirement. For example, in Warsaw a 
budget of EUR 1.2 million (PLN 5 million) was allocated to the 
strategy. These funds were solely derived from the ‘cork tax’, 
or alcohol licensing revenue, that communes have been 
entitled to use to fund drugs strategies since the 2005 Act on 
Counteracting Drug Addiction became law.
Vienna’s SDW is allocated a budget to implement drugs 
strategy on the basis of a performance agreement with the 
municipal authorities responsible for public health. In Prague, 
a range of services from prevention to treatment are funded 
from the city’s overall budget each year. In Ireland, 
EUR 20 million was allocated to local drugs task forces 
(LDTFs) throughout the country in 2011. While not 
representing a budget for Dublin city’s response to drug 
issues, the amount allocated to the three LDTFs covering the 
city totalled EUR 6.2 million. In Vilnius, drugs policy 
interventions implemented under the Healthcare Protection 
Programme received a total of EUR 187 000 in 2012. In 
Helsinki, EUR 50 million was spent by the Social Services 
Department on services for drug users in 2010. A total of 
EUR 22.1 million was spent by the municipality of Copenhagen 
in 2011 on implementing its Plan on Drug Abuse (2011–2014).
These figures can give an indication of the amounts of funds 
that are earmarked for implementing city-level drugs 
strategies or of how much it costs to purchase certain 
services such as drug treatment. However, these very different 
sets and types of figures do not provide a European-level 
picture of drugs strategy-linked expenditure. In many cases, 
there is patchy information available at city level; in others, 
none at all is available, as funds are allocated from central 
sources and breakdowns are not obtainable.
I Conclusions
At city level, drug use is a complex phenomenon that shifts 
between legal and illegal behaviours. An array of substances 
is used by different types of drug consumers in a variety of 
settings. The use of drugs damages the fabric of the city for 
some, while for others the city provides anonymity for 
problematic use or recreational hedonism. Equally, these 
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and substitution treatment programmes show the potential 
that cities have to respond to drug problems. However, this 
cooperation is something that will continue to be tested as 
European cities become more densely populated, with an 
increase from the current 73 % of the population that reside in 
cities to 82 % (or 30 million new residents) by 2050 (European 
Commission, 2015). At the same time drug problems will 
persist and become more centred on complex polydrug-using 
practices and the attendant health problems that these bring.
In this context, services at the front line, such as those offering 
low-threshold access, will continue to come under operational 
pressure. It is these services that are first to respond to 
changes in drug use and drug scenes, whether it is at the 
recreational or problematic end of the spectrum. Delivering 
interventions in response to emergent and dynamic drug 
problems will depend on continuing cooperation and resource 
prioritisation between city authorities and the various 
stakeholders involved in drugs policy.
Nonetheless, a trend exists towards the use of city-level drugs 
strategies, whether for drug use generally or to target specific 
issues. While strategies provide those working in the area with 
a joint operating statement, cross-sectoral collaboration is 
hindered by a lack of designated coordination structures that 
have achieved stakeholder validation and participation. This is 
further compounded by funding for services and other 
responses coming under pressure during a time of ongoing 
austerity in the European Union, while there is no evidence of 
a trend towards the allocation of dedicated budgets for 
city-level drugs strategies.
Most city-level drugs policy responses involve diverse groups 
of stakeholders working together. This results in the delivery of 
a wide range of services at multiple levels of intervention for 
different drug problems. In this way, examples of health, 
community sector, municipal and police services working 
together to deliver and to facilitate the operation of needle and 
syringe exchange programmes, drug consumption facilities 
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